SUVOREXANT - AN OVERVIEW

Steer clear of coadministration with sensitive CYP3A substrates. If coadministration unavoidable, watch for adverse reactions and reduce CYP3A substrate dose in accordance with solution labeling.Use Warning/Keep an eye on. Ethinyl estradiol may possibly inhibit the clearance of benzodiazepines that bear oxidation, therefore raising serum concentrat